Compumedics Limited Reports Strong Growth in USA and Europe

Compumedics Limited (AU:CMP) has released an update.

Compumedics Limited has reported a remarkable 136% increase in sales orders in its USA market, driven by the success of its sleep and Somfit business, with Somfit sales nearing $1 million. In Europe, the company secured a significant contract in Poland, further strengthening its position in the region. Compumedics continues to build momentum in both markets, reaffirming its sales growth strategy for FY25.

For further insights into AU:CMP stock, check out TipRanks’ Stock Analysis page.